A Systematic Review of Cognitive and Behavioural Symptoms in CTNNB1 Syndrome

Basu, A.P., Low, K., Ratnaike, T., & Rowitch, D. (2024). Genetic investigations in cerebral palsy. Developmental Medicine & Child Neurology, 1–9. https://doi.org/10.1111/dmcn.16080

Bawor, M., Dennis, B. B., Anglin, R., Steiner, M., Thabane, L., & Samaan, Z. (2014). Sex differences in outcomes of methadone maintenance treatment for opioid addiction: A systematic review protocol. Systematic Reviews, 3, 45. https://doi.org/10.1186/2046-4053-3-45

Article  PubMed  PubMed Central  Google Scholar 

Bulot, V., Ramond, F., Mauguière, F., & Mazzola, L. (2022). Startle disease: An overlooked symptom of CTNNB1-related neurodevelopmental disorder with spastic diplegia and visual defects. Neurology Genetics, 8(6), e200039. https://doi.org/10.1212/NXG.0000000000200039

Article  PubMed  PubMed Central  Google Scholar 

Caracci, M.O., Avila, M.E., Espinoza-Cavieres, F.A., López, H.R., Ugarte, G.D., & De Ferrari, G.V. (2021). Wnt/β-catenin-dependent transcription in autism spectrum disorders. Frontiers in Molecular Neurosciences, 14. https://doi.org/10.3389/fnmol.2021.764756

Chaves, L. D., Caravalho, L. M. L., Tolezano, G. C., Pires, S. F., Costa, S. S., de Scliar, M. O., Giuliani, L. R., Bertola, D. R., Santos-Rebouças, C. B., Seo, G. H., Otto, P. A., Rosenberg, C., Vianna-Morgante, A. M., & Krepischi, A. C. V. (2023). Skewed X-chromosome inactivation in women with idiopathic intellectual disability is indicative of pathogenic variants. Molecular Neurobiology, 60(7), 3758–3769. https://doi.org/10.1007/s12035-023-03311-0

Article  CAS  PubMed  Google Scholar 

Cordeiro, D., Bullivant, G., Siriwardena, K., Evans, A., Kobayashi, J., Cohn, R. D., & Mercimek-Andrews, S. (2018). Genetic landscape of pediatric movement disorders and management implications. Neurology Genetics, 4(5), e265. https://doi.org/10.1212/NXG.0000000000000265

Article  PubMed  PubMed Central  Google Scholar 

Coussa, R. G., Zhao, Y., DeBenedictis, M. J., Babiuch, A., Sears, J., & Traboulsi, E. I. (2020). Novel mutation in CTNNB1 causes familial exudative vitreoretinopathy (FEVR) and microcephaly: Case report and review of the literature. Ophthalmic Genetics, 41(1), 63–68. https://doi.org/10.1080/13816810.2020.1723118

Article  CAS  PubMed  Google Scholar 

Dashti, S., Salehpour, S., Ghasemi, M. R., Sadeghi, H., Rostami, M., Hashemi-Gorji, F., Mirfakhraie, R., Yassaee, V. R., & Miryounesi, M. (2022). Identification of a novel de novo mutation in the CTNNB1 gene in an Iranian patient with intellectual disability. Neurological Sciences, 43(4), 2859–2863. https://doi.org/10.1007/s10072-022-05904-4

Article  PubMed  Google Scholar 

de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., del Rosario, M., Hoischen, A., Scheffer, H., de Vries, B. B. A., Brunner, H. G., Veltman, J. A., & Vissers, L. E. L. M. (2012). Diagnostic exome sequencing in persons with severe intellectual disability. New England Journal of Medicine, 367(20), 1921–1929. https://doi.org/10.1056/NEJMoa1206524

Article  CAS  PubMed  Google Scholar 

Dixon, M. W., Stem, M. S., Schuette, J. L., Keegan, C. E., & Besirli, C. G. (2016). CTNNB1 mutation associated with familial exudative vitreoretinopathy (FEVR) phenotype. Ophthalmic Genetics, 37(4), 468–470. https://doi.org/10.3109/13816810.2015.1120318

Article  PubMed  Google Scholar 

Dubruc, E., Putoux, A., Labalme, A., Rougeot, C., Sanlaville, D., & Edery, P. (2014). A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency. American Journal of Medical Genetics Part A, 146A(6), 1571–1575. https://doi.org/10.1002/ajmg.a.36484

Article  CAS  Google Scholar 

Gonzalez-Mantilla, P. J., Hu, Y., Myers, S. M., Finucane, B. M., Ledbetter, D. H., Martin, C. L., & Moreno-De-Luca, A. (2023). Diagnostic yield of exome sequencing in cerebral palsy and implications for genetic testing guidelines: A systematic review and meta-analysis. JAMA Pediatrics, 177(5), 472–478. https://doi.org/10.1001/jamapediatrics.2023.0008

Article  PubMed  PubMed Central  Google Scholar 

Ho, S.K.L., Tsang, M.H.Y., Lee, M., Cheng, S.S.W., Luk, H.L., Lo, I.F.M., & Chung, B.H.Y. (2022). CTNNB1 neurodevelopmental disorder. Gene Reviews [Internet]. University of Washington.

Ho, S., Tsang, M. H., Fung, J. L., Huang, H., Chow, C. B., Cheng, S. S., Luk, H. M., Chung, B. H. Y., & Lo, I. F. (2022b). CTNNB1-related neurodevelopmental disorder in a Chinese population: A case series. American Journal of Medical Genetics. Part A, 188(1), 130–137. https://doi.org/10.1002/ajmg.a.62504

Article  CAS  PubMed  Google Scholar 

Ji, Y., Xia, Q., Zhang, H., Huo, H., Cao, X., Wang, W., & Gu, Q. (2023). Whole exome sequencing identified two novel truncation mutations in the CTNNB1 gene associated with neurodevelopmental disorder, language dysfunction, and microcephaly in Chinese children. Child Neurology Open, 10. https://doi.org/10.1177/2329048X231184184

Jin, S.C., Lewis, S.A., Bakhtiari, S., Zeng, X., Sierant, M.C., Shetty, S., Nordile, S.M., Elie, A., Corbett, M.A., Norton, B.Y., van Eyk, C.L., Haider, S., Guida, B.S., Magee, H., Liu, J., Pastore, S. Vincent, J.B., Brunstrom-Hernandez, J., Papavasileiou, A., … Kruer, M.C. (2020). Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nature Genetics, 52(10), 1046-1056. https://doi.org/10.1038/s41588-020-0695-1

Kayumi, S., Pérez-Jurado, L.A., Palomares, M., Rangu, S., Sheppard, S.E., Chung, W.K., Kruer, M.C., Kharbanda, M., Amor, D.J., McGillivray, G., Cohen, J.S., García-Miñaúr, S., van Eyk, C.L., Harper, K., Jolly, L.A., Webber, D.L., Barnett, C.P., Santos-Simarro, F., Pacio-Míguez, M., … Corbett, M.A. (2022). Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants. Genetics in Medicine, 24 (11), 2351–2366. https://doi.org/10.1016/j.gim.2022.08.006

Ke, Z., & Chen, Y. (2020). Case report: A de novo CTNNB1 nonsense mutation associated with neurodevelopmental disorder, retinal detachment, polydactyly. Frontiers in Pediatrics, 8. https://doi.org/10.3389/fped.2020.575673

Keeratisitoj, O., Thawinchai, N., Siritaratiwat, W., Buntragulpoontawee, M., & Pratoomsoot, C. (2018). Prognostic predictors for ambulation in children with cerebral palsy: A systematic review and meta-analysis of observational studies. Disability and Rehabilitation, 40(2), 135–143. https://doi.org/10.1080/09638288.2016.1250119

Article  Google Scholar 

Kharbanda, M., Pliz, D. T., Tomkins, S., Chandler, K., Saggar, A., Fryer, A., McKay, V., Louro, P., Smith, J. C., Burn, J., Kini, U., De Bruca, A., FitzPatrick, D. R., Kinning, E., Study DDD. (2017). Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals. European Journal Medical Genetics, 60(2), 130–135. https://doi.org/10.1016/j.ejmg.2016.11.008

Article  Google Scholar 

Krupp, D. R., Barnard, R. A., Duffourd, Y., Evans, S. A., Mulqueen, R. M., Bernier, R., Rivière, J. B., Fombonne, E., & O’Roak, B. J. (2017). Exonic mosaic mutations contribute risk for autism spectrum disorder. The American Journal of Genetics, 101(3), 369–390. https://doi.org/10.1016/j.ajhg.2017.07.016

Article  CAS  Google Scholar 

Kuechler, A., Willemsen, M.H., Albrecht, B., Bacino, C.A., Bartholomew, D.W, van Bokhoven, H., van den Boogaard, M.J.H., Bramswig, N., Büttner, C., Cremer, K., Czeschik, J.C., Engels, H., van Gassen, K., Graf, E., van Haelst, M., He, W., Hogue, J.S., Kempers, M., Koolen, D., ... Wieczorek, D. (2015). De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: Expanding the mutational and clinical spectrum. Human Genetics, 134 (1), 97–109. https://doi.org/10.1007/s00439-014-1498-1

Lee, S., Jang, S.S., Park, S., Yoon, J.G., Kim, S.Y., Lim, B.C., & Chae, J.H. (2022). The extended clinical and genetic spectrum of CTNNB1-related neurodevelopmental disorder. Frontiers in Pediatrics, 10. https://doi.org/10.3389/fped.2022.960450

Lee, J., Yoo, J., Lee, S., & Jang, D.H. (2023). CTNNB1-related neurodevelopmental disorder mimics cerebral palsy: Case report. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1201080

Li, N., Xu, Y., Li, G., Yu, T., Yao, R., Wang, X., & Wang, J. (2017). Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay: Case report and literature review. Medicine, 96(20), e6914. https://doi.org/10.1097/MD.0000000000006914

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maguschak, K. A., & Ressler, K. J. (2012). The dynamic role of beta-catenin in synaptic plasticity. Neuropharmacology, 62(1), 78–88. https://doi.org/10.1016/j.neuropharm.2011.08.032

Article  CAS  PubMed  Google Scholar 

Miroševič, S., Khandelwal, S., Sušjan, P., Žakelj, N., Gosar, D., Forstnerič, V., Lainšček, D., Jerala, R., & Osredkar, D. (2022). Correlation between phenotype and genotype in CTNNB1 syndrome: A systematic review of literature. Molecular Sciences, 23(20). https://doi.org/10.3390/ijms232012564

Moeinafshar, A., Tehrani-Fateh, S., Sadeghi, H., Karimzadeh, P., Mirfakhraie, R., Hashemi-Gorji, F., Larki, P., Miryounesi, M., & Ghasemi, M. R. (2023). Alopecia areata-like pattern of baldness: The most recent update and the expansion of novel phenotype and genotype in CTNNB1 gene. Neurological Sciences, 44(11), 4041–4048. https://doi.org/10.1007/s10072-023-06922-6

Article  PubMed  Google Scholar 

Nagy, N., Pál, M., Nagy, D., Bokor, B. A., Zimmermann, A., Gellén, B., Salamon, A., Sztriha, L., Klivényi, P., & Széll, M. (2024). A novel de novo truncating variant in a Hungarian patient with CTNNB1 neurodevelopmental disorder. BMC Pediatrics, 24(47), 1–6. https://doi.org/10.1186/s12887-023-04509-w

Article  Google Scholar 

Onesimo, R., Sforza, E., Trevisan, V., Leoni, C., Giorgio, V., Rigante, D., Kuczynska, E.M., Proli, F., Agazzi, C., Limongelli, D., Digilio, M.C., Dentici, M.L., Macchiaiolo, M., Novelli, A., Bartuli, A., Sinibaldi, L., Tartaglia, M., & Zampino, G. (2023). From feeding challenges to oral-motor dyspraxia: A comprehensive description of 10 new cases with CTNNB1 syndrome. Genes, 14(10). https://doi.org/10.3390/genes14101843

Panagiotou, E. S., Sanjuro-Soriano, C., Poulter, J. A., Lord, E. C., Dzulova, D., Kondo, H., Hiyoshi, A., Chung, B. H., Chu, Y. W., Lai, C. H. Y., Tafoya, M. E., Karjosukarso, D., Collin, R. W. J., Topping, J., Downey, L. M., Ali, M., Inglehearn, C. F., & Toomes, C. (2017). Defects in the cell signaling mediator β-catenin cause the retinal vascular condition FEVR. The American Journal of Human Genetics, 100(6), 960–968. https://doi.org/10.1016/j.ajhg.2017.05.001

Article  CAS  PubMed  Google Scholar 

Paparella, A., Squeo, G. M., Di Venere, E., Cardea, E., Mazza, T., Castellana, S., Kerkhof, J., McConkey, H., Sadikovic, B., Sinibaldi, L., Digilio, M. C., & Merla, G. (2022). Genome-wide DNA methylation profiling and exome sequencing resolved a long-time misdiagnosed case. Journal of Human Genetics, 67(9), 547–551. https://doi.org/10.1038/s10038-022-01043-y

Article  CAS  PubMed  Google Scholar 

Percy, A. K., Lane, J., Annese, F., Warren, H., Skinner, S. A., & Neul, J. L. (2018). When Rett syndrome is due to genes other than MECP2. Translational Science of Rare Disease, 3(1), 49–53. https://doi.org/10.3233/TRD-180021

Article  Google Scholar 

Pipo-Deveza, J., Fehlings, D., Chitayat, D., Yoon, G., Sroka, H., & Tein, I. (2018). Rationale for dopa-responsive CTNNB1/ β -catenin deficient dystonia. Movement Disorders, 33(4), 656–657. https://doi.org/10.1002/mds.27320

Article  PubMed  Google Scholar 

Prasad, M.K., Geoffroy, V., Vicaire, S., Jost, B., Dumas, M., Le Gras, S., Switala, M., Gasse, B., Laugel-Haushalter, V., Paschaki, M., Leheup, B., Droz, D., Dalstein, A., Loing, A. Grollemund, B., Muller-Bolla, M., Lopez-Cazaux, S., Minoux, M., Jung, S., … Bloch-Zupan, A. (2016). A targeted next-generation sequencing assay for the molecular diagnosis of genetic disorders with orodental involvement. Journal of Medical Genetics, 53(2), 98–110. https://doi.org/10.1136/jmedgenet-2015-103302

Retterer, K., Juusola, J., Cho, M.T., Vitazka, P., Millan, F., Gibellini, F., Vertino-Bell, A., Smaoui, N., Neidich, J., Monaghan, K.G., McKnight, D., Bai, R., Suchy, S., Friedman, B., Tahiliani, J., Pineda-Alvarez, D., Richard, G., Brandt, T., Haverfield, E., … Bale, S. (2016). Clinical application of whole-exome sequencing across clinical indications. Genetics in Medicine, 18(7), 696–704. https://doi.org/10.1136/jmedgenet-2015-103302

Rossetti, L. Z., Bekheirnia, M. R., Lewis, A. M., Mefford, H. C., Golden-Grant, K., Tarczy-Hornoch, K., Briere, L. C., Sweetser, D. A., Walker, M. A., Kravets, E., Stevenson, D. A., Bruenner, G., Sebastian, J., Knapo, J., Rosenfeld, J. A., Marcogliese, P. C., & Wrangler, M. F. (2020). Missense variants in CTNNB1 can be associated with vitreoretinopathy - Seven new cases of CTNNB1-associated neurodevelopmental disorder including a previously unreported retinal phenotype. Molecular Genetics & Genomic Medicine, 9(1), e1542. https://doi.org/10.1002/mgg3.1542

Article  CAS 

Comments (0)

No login
gif